Zydus Lifesciences Ltd.

Zydus Cadila, an innovative global pharmaceutical company, has received US Food Drug and Administrator (USFDA) approval for Irbesartan Tablets USP 75 mg, 150 mg and 300 mg. Irbesartan is a drug used in the treatment of hypertension. As per NDC, the estimated sales in 2011 for Irbesartan Tablets was $489 million.

With this approval, the group now has 72 approvals and has so far filed 150 ANDAs since the commencement of filing process in FY 2003-04.

Flagship company of Zydus Cadila Group, it focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.